EWM
IDXX icon

Elevatus Welath Management’s Idexx Laboratories IDXX Stock Holding History

Elevatus Welath Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$228K Buy
+434
New +$243K 0.06% 220

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Elevatus Welath Management's IDXX Position: Q2 2026 in Review

Elevatus Welath Management opened a new position in Idexx Laboratories (IDXX) in Q2 2026: 434 shares worth $228K. The stake represents 0.06% of the portfolio and ranks #220 among its holdings.

1,296 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Elevatus Welath Management held 434 shares of Idexx Laboratories worth $228K as of Q2 2026.
  • Idexx Laboratories was a new Elevatus Welath Management position in Q2 2026.
  • Idexx Laboratories made up 0.06% of Elevatus Welath Management's portfolio in Q2 2026, its #220 holding.
  • 1,296 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Elevatus Welath Management's 13F filing for Q2 2026, filed 13 Aug 2026.